
    
      The study is "PG2 Treatment for Improving Fatigue among Advanced Cancer Patients under
      Standard Palliative Care" (Protocol Number: PH-CP012) of the additional plan, through
      questionnaires and using actigraphy measuring circadian rhythm collect patient data master
      plans, assessed for "PG2" treatment of cancer patients before and after treatment fatigue,
      depression, sleep disorders and other related symptoms of resistance and the effectiveness of
      treatment, and to further explore the symptom clusters in cancer patients associated with the
      circadian rhythm
    
  